BB Biotech AG
Healthcare · GBP · SIX
Price
£44.5
Cap
£4.63B
Earnings
—
30d Trend
-1.0%
27% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 68×Macro 0.99 (−1%)=67
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Long-term compounder with 4.3% yield
BRAIN47'S ASSESSMENT
I rate BB Biotech AG at 67/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 78/100. I classify this as a income position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
-2.8%
3 MONTHS
-0.7%
12 MONTHS
+58.5%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Long-term compounder with 4.3% yield. Momentum (78) and Fundamentals (71) are the primary strengths. Historical volatility is moderate at 27%. I classify this as an income position — the 4.3% yield combined with the dividend profile makes it suitable for income generation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.